Review and consensus on pharmacogenomic testing in psychiatry
2024
Review of Pharmacogenomic Testing in Psychiatry
Editorial
Author Information
Author(s): Faiz Mark, Ahmed Sanjida
Primary Institution: Personalized Prescribing Inc., Toronto, ON, Canada
Hypothesis
Can pharmacodynamic algorithms improve pharmacogenomic testing for antidepressants?
Conclusion
Pharmacodynamic algorithms could enhance the effectiveness of pharmacogenomic tests by providing a more comprehensive understanding of drug efficacy.
Supporting Evidence
- Testing for CYP2D6 and CYP2C19 is important but not sufficient for determining drug efficacy.
- Almost 90% of all ethnicities have normal or moderate metabolism of antidepressants.
- Pharmacodynamics requires a polygenic analysis rather than a one-gene approach.
Takeaway
This study suggests that looking at many genes together can help doctors choose the right medicine for their patients better than just looking at one or two genes.
Limitations
Limited research exists on how polygenic pharmacodynamics influences antidepressants.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website